Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSCW) Preferred Stock Liabilities (2020)

Historic Preferred Stock Liabilities for Ensysce Biosciences (ENSCW) over the last 1 years, with Q4 2020 value amounting to $52935.0.

  • Ensysce Biosciences' Preferred Stock Liabilities changed N/A to $52935.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $52935.0, marking a year-over-year change of. This contributed to the annual value of $52935.0 for FY2020, which is N/A changed from last year.
  • Ensysce Biosciences' Preferred Stock Liabilities amounted to $52935.0 in Q4 2020.
  • In the past 5 years, Ensysce Biosciences' Preferred Stock Liabilities ranged from a high of $4.5 million in Q1 2020 and a low of $52179.0 during Q2 2020